BeiGene to Host Investor Conference Call and Webcast to Discuss the Company’s Early Development Pipeline and Research on August 25, 2021

Rhea-AI Summary

BeiGene, Ltd. (NASDAQ: BGNE) announced an investor conference call on August 25, 2021, at 9:30 a.m. ET to discuss its early development pipeline and research initiatives. The event will be accessible via a live webcast on BeiGene’s investor website, with an archived replay available for 90 days post-event. BeiGene is committed to innovative and affordable medicines aimed at enhancing patient access, with a portfolio of over 40 clinical candidates and a goal of improving access for two billion people by 2030. The company has a global team of around 7,000 employees.

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, today announced that it will host an investor conference call and webcast on Wednesday, August 25, 2021, at 9:30 a.m. ET to discuss the Company’s early development pipeline and research.

A live webcast of the conference call can be accessed from the investors section of BeiGene’s website at http://ir.beigene.com or http://hkexir.beigene.com. An archived replay will be available after the event for 90 days.

About BeiGene

BeiGene is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. With a broad portfolio of more than 40 clinical candidates, we are expediting development of our diverse pipeline of novel therapeutics through our own capabilities and collaborations. We are committed to radically improving access to medicines for two billion more people by 2030. BeiGene has a growing global team of approximately 7,000 colleagues across five continents. To learn more about BeiGene, please visit www.beigene.com and follow us on Twitter at @BeiGeneGlobal.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210816005187/en/

FAQ

What is the date and time of BeiGene's investor conference call?

BeiGene's investor conference call is scheduled for August 25, 2021, at 9:30 a.m. ET.

How can I access the BeiGene conference call webcast?

The conference call can be accessed via BeiGene’s investor website at http://ir.beigene.com.

Will the BeiGene conference call be available for replay?

Yes, an archived replay of the conference call will be available for 90 days after the event.

What topics will be discussed during the BeiGene investor conference call?

The conference call will focus on BeiGene’s early development pipeline and research initiatives.

What is BeiGene’s goal regarding access to medicines by 2030?

BeiGene aims to improve access to medicines for two billion more people by the year 2030.